Lupin submits copy of revised press release

01 Dec 2016 Evaluate

Lupin vide its letter dated December 01, 2016 has submitted a copy of Revised Press Release as regards expansion of partnership with Eli Lilly and Company (India) (Lilly), to market and sell Lillys rapid-acting Insulin analog Lispro under the brand name Eglucent.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×